Resonance HealthASX:RHT +4.55% Market Cap is A$21.95 Mil as of Jun. 24, 2026. The stock has 6 warning signs investors should review. Among 697 Healthcare Providers & Services companies, Resonance Health ranks worse than 78.19% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Resonance Health's share price for the quarter that ended in Dec. 2025 was A$0.049. Resonance Health's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 474.79 Mil. Therefore, Resonance Health's market cap for the quarter that ended in Dec. 2025 was A$23.26 Mil.
Resonance Health's quarterly market cap
declined
from Dec. 2024 (A$23.90 Mil) to Jun. 2025 (A$17.94 Mil) but then
increased
from Jun. 2025 (A$17.94 Mil) to Dec. 2025 (A$23.26 Mil).
Resonance Health's annual market cap
increased
from Jun. 2023 (A$19.37 Mil) to Jun. 2024 (A$26.37 Mil) but then
declined
from Jun. 2024 (A$26.37 Mil) to Jun. 2025 (A$17.94 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Resonance Health's Enterprise Value for Today is A$23.31 Mil.
Resonance Health (ASX:RHT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Resonance Health Market Cap Related Terms
Resonance Health Market Cap Historical Data
* Premium members only.
The historical data trend for Resonance Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Resonance Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonance Health Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Resonance Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Resonance Health's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Resonance Health (ASX:RHT) has a Market Cap of A$21.95 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Resonance Health and its competitors. According to the industry distribution chart, Resonance Health ranks #545 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 78.2%.
Is Resonance Health's Market Cap too high?
Resonance Health's current Market Cap is A$21.95 Mil. Based on the distribution chart, Resonance Health ranks #545 out of 697 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Resonance Health's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Resonance Health ranks #545 out of 697 companies for Market Cap. This places Resonance Health in the lower half of its industry. The industry median Market Cap is 95.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 95.30, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Resonance Health and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 95.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonance Health's current Market Cap is A$21.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonance Health stock overvalued right now?
Based on GuruFocus' analysis, Resonance Health (ASX:RHT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.12, compared to a current price of A$0.05 — trading 61.7% below its estimated fair value. The current Market Cap is A$21.95 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Resonance Health (ASX:RHT), the current Market Cap is A$21.95 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Resonance Health Ltd is engaged in the development and commercialisation of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group's core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are; SaMD1 which derives key revenue, Corporate, TrialsWest, and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHT has been successfully added to your 